Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Sci Total Environ ; 951: 175350, 2024 Aug 06.
Artigo em Inglês | MEDLINE | ID: mdl-39117197

RESUMO

Micro-nanoplastic particulates (MNPs) have been identified in both indoor and outdoor environments. From these real-world exposures, MNPs have been identified in human fluids and organ tissues, including the placenta and breastmilk. Laboratory studies have identified MNPs are capable of crossing the placental barrier and depositing in fetal tissues; however, it remained unclear if MNPs persist in offspring tissues after birth. Six pregnant Sprague-Dawley rats were divided equally into two groups: control and exposed to polyamide-12 (PA-12) MNP aerosols (11.46 ± 3.78 mg/m3) over an average of 4.35 h ± 0.39 for 10 non-consecutive days between gestational day (GD) 6 - GD 19, in our custom rodent exposure chamber, allowing for whole-body inhalation. Two-weeks after delivery in-house, offspring tissues (i.e. lung, liver, kidney, heart, brain) from 1 male and 1 female pup per litter were fixed in 4 % paraformaldehyde, sectioned, stained with hematoxylin and eosin, and assessed using hyperspectral dark-field microscopy. PA-12 MNPs were identified in all offspring tissues of the exposed dams. No MNPs were visualized in control tissues. These findings have important implications for human MNPs translocation, deposition, maternal/fetal health, and the developmental origins of health and disease. Further research is warranted to quantify MNPs mass deposition, biological accumulation, and systemic toxicity.

2.
Eur J Gastroenterol Hepatol ; 20(1): 73-8, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18090995

RESUMO

We have investigated two cases of acute hepatitis C that occurred in patients who underwent digestive endoscopy and contrast-enhanced computed tomography (CT) scanning at two different centers. Investigations to identify the sources of infection included an on-site review of diagnostic procedures, interview of the involved healthcare staff, serological testing of the patients who underwent the procedures before and after the index cases and a molecular analysis of viral isolates from the patients and from potential viremic sources. In both cases, the epidemiological investigation identified a chronic hepatitis C virus (HCV) carrier who had been subjected to CT-scanning immediately before the index patient. Genetic distance and molecular phylogenetic analyzes of HCV sequences showed a close relationship between the isolates from these carriers and those from the acute-hepatitis patients, strongly suggesting that patient-to-patient transmission had occurred during CT. This is the first report describing two well documented cases of HCV nosocomial patient-to-patient transmission during contrast-enhanced CT scanning.


Assuntos
Colonoscopia/efeitos adversos , Infecção Hospitalar/transmissão , Hepatite C/transmissão , Transmissão de Doença Infecciosa do Profissional para o Paciente , Tomografia Computadorizada por Raios X/efeitos adversos , Doença Aguda , Adulto , Contaminação de Equipamentos , Hepacivirus/genética , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco
3.
Diagn Microbiol Infect Dis ; 53(2): 93-9, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16168618

RESUMO

To assess the role of phylogenetic background and putative virulence factors (VFs) in Escherichia coli causing urinary bacteremia, 50 strains isolated from this condition were compared with 50 strains isolated from pyelonephritis and 50 from other sources of bacteremia. papA and papGII were significantly more prevalent in urinary bacteremia and pyelonephritis (78%, 66% and 70%, 58%) than in other-source bacteremia (48% and 24%), whereas sfa/focDE and cnf1 were more prevalent in urinary-source bacteremia (56% and 44%) than in pyelonephritis and other-source bacteremia (28%, 42% and 20%, 28%). Group B2 was the most frequent in all conditions (63% of isolates) and exhibited the greatest concentration of VFs. Urinary tract bacteremia, pyelonephritis, and other-source bacteremia isolates presented similar virulence scores (7.8, 7.0, and 6.6); however, there were striking differences among the phylogenetic groups (8.7 in group B2 versus 3.4 in group A; P < .001). Group A and B1 strains almost exclusively infected compromised hosts.


Assuntos
Bacteriemia/microbiologia , Infecções por Escherichia coli/microbiologia , Escherichia coli/classificação , Escherichia coli/patogenicidade , Pielonefrite/microbiologia , Infecções Urinárias/microbiologia , Bacteriemia/epidemiologia , Escherichia coli/genética , Infecções por Escherichia coli/sangue , Infecções por Escherichia coli/epidemiologia , Humanos , Fatores de Virulência
4.
Eur J Gastroenterol Hepatol ; 14(1): 81-3, 2002 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11782580

RESUMO

Prophylaxis with norfloxacin has been shown to be effective in preventing spontaneous bacterial peritonitis (SBP) in liver cirrhosis. This therapy is associated with the appearance of quinolone-resistant Escherichia coli. However, only four cases of SBP caused by quinolone-resistant E. coli have been reported so far. We present four cases of quinolone-resistant E. coli SBP in three patients receiving oral quinolones, and who were on corticosteroid therapy to treat associated disorders.


Assuntos
Anti-Infecciosos/uso terapêutico , Antibioticoprofilaxia , Infecções por Escherichia coli/diagnóstico , Escherichia coli/efeitos dos fármacos , Cirrose Hepática/complicações , Peritonite/microbiologia , Peritonite/prevenção & controle , Idoso , Anti-Infecciosos/farmacologia , Farmacorresistência Bacteriana , Infecções por Escherichia coli/etiologia , Evolução Fatal , Feminino , Glucocorticoides/uso terapêutico , Hepatite C/complicações , Humanos , Masculino , Pessoa de Meia-Idade , Norfloxacino/farmacologia , Norfloxacino/uso terapêutico , Peritonite/etiologia , Prednisona/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA